We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00469521
Recruitment Status : Completed
First Posted : May 4, 2007
Last Update Posted : September 10, 2007
Sponsor:
Information provided by:
Innovative Medical

Brief Summary:
To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.

Condition or disease Intervention/treatment Phase
Tear Film Thickness Drug: Refresh Tears, 9582X Phase 4

Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tears
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  1. Normal, healthy volunteers 18 years or older
  2. Males or females
  3. Any race or ethnic background

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00469521


Locations
United States, South Carolina
Magill Research Center Institute MUSC
Charleston, South Carolina, United States, 29425
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Helga Sandoval, MS, MD Magill Research Center Institute MUSC

ClinicalTrials.gov Identifier: NCT00469521     History of Changes
Other Study ID Numbers: 5304
First Posted: May 4, 2007    Key Record Dates
Last Update Posted: September 10, 2007
Last Verified: September 2007